Ibio Inc (IBIO) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ibio inc   (NASDAQ: IBIO)


Ibio Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ibio Inc's ROI in the fourth quarter of 2026?
Ibio Inc recorded a cumulative net loss of $-33 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -54.65%.

Within the Healthcare sector 504 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3846, from total ROI ranking in the third quarter of 2026 at 4683.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 209.37 % 104.7 % 7.9 % 22.22 % -13.34 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 87 79 17 58 19
Return On Investment (TTM) -54.65 % -63.81 % -92.1 % -69.79 % -94.02 %
IBIO's Overall Ranking # 3846 # 4683 # 4009 # 4184 # 4259
Seq. Investment Change TTM 39.77 % 61.09 % -6.78 % 47.4 % -7.52 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -33 -28 -25 -20 -18

IBIO Company Profile >> Back to IBIO Roi Comparisons >> See Annual IBIO Return On Investment



Return On Investment IBIO's Ranking
Within: No.
Industry # 217
Sector # 505
Overall # 3846

Return On Investment Statistics
High Average Low
-19.42 %
-71.09 %
-172.67 %
(Jun 30 2021)   (Sep 30 2012)







Financial Statements
Ibio Inc's IV. Quarter Investments $ 87 Millions IBIO's Balance sheet
Ibio Inc's IV. Quarter Income $ -11 Millions Quarterly IBIO's Income Statement
IBIO's Income by Division See IBIO's Income by Division


IBIO Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 87 17 25 20 69
Y / Y Investment Growth 411.53 % -31.39 % 26.85 % -71.55 % -50.85 %
Net Income in Millions -33 -18 -25 -65 -50
Y / Y Net Income Growth - - - - -
Annual Return On Investment -37.82 % -107.6 % -100.05 % -331.26 % -72.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IBIO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IBIO's Competitors
Subscribers only: Roi for Ibio Inc's Suppliers
Subscribers only: Return On Investment for IBIO's Customers

Other Ratios
IBIO's Roa IBIO's Inventory Turnover Ratio IBIO's Growth Rates IBIO's Dividend Statistics
IBIO's Profitability Ratios IBIO's Asset Turnover Ratio IBIO's Dividend Growth
IBIO's Roe IBIO's Valuation Ratios IBIO's Financial Strength Ratios IBIO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-29T06:23:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.